Ovarian Cancer
Showing NaN - NaN of 107
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Effect of PARP Inhibitors on Glomerular Filtration Rate
Terminated
- Solid Tumor
- +2 more
- Kidney Function Test
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 20, 2022
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L/Montanide ISA 51 VG, Ampligen,
Terminated
- Ovarian Cancer
- +2 more
- OC-L/Montanide ISA 51 VG
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 18, 2021
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (Rucaparib)
Completed
- Ovarian Cancer
- +3 more
-
San Francisco, California
- +15 more
Jan 19, 2021
Compare Fallopian Tube Cells Collected by Cytuity With Removed
Completed
- Fallopian Tube Cancer
- +10 more
- Hysteroscopic cell sampling of the fallopian tube
-
San Diego, California
- +9 more
Dec 30, 2020
Ovarian Cancer, Tumors, Carcinoma Trial in Philadelphia (enzastaurin)
Completed
- Ovarian Cancer
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group 215-854-0770
Nov 24, 2020
Malignant Pleural Effusion, Lung Cancer, Mesothelioma Trial in Philadelphia (AdV-tk + valacyclovir)
Completed
- Malignant Pleural Effusion
- +4 more
- AdV-tk + valacyclovir
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 2, 2020
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,
Completed
- Epithelial Ovarian Cancer
- +3 more
- Mirvetuximab soravtansine
- +3 more
-
Birmingham, Alabama
- +130 more
Sep 24, 2020
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in United States (Paclitaxel, Carboplatin, Avastin)
Active, not recruiting
- Ovarian Cancer
- +2 more
- Paclitaxel
- +2 more
-
Baltimore, Maryland
- +4 more
Aug 17, 2020
Ovarian Cancer Trial in New York, Oklahoma City, Philadelphia (OMP-54F28, Paclitaxel and Carboplatin)
Completed
- Ovarian Cancer
- OMP-54F28, Paclitaxel and Carboplatin
-
New York, New York
- +3 more
Aug 11, 2020
TeleGenetics Versus Usual Care To Increase Access To Cancer
Completed
- Breast Cancer
- +2 more
- Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 3, 2020
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
Completed
- Uterine Cancer
- +5 more
- Survey
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 28, 2020
Ovarian Cancer Trial in Philadelphia (Exercise)
Completed
- Ovarian Cancer
- Exercise
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 15, 2020
Ovarian Cancer, Pancreatic Cancer Trial in Philadelphia (Agent VM110 and laproscopic infra-red probe)
Terminated
- Ovarian Cancer
- Pancreatic Cancer
- Agent VM110 and laproscopic infra-red probe
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 3, 2020
Physician-Patient Communication and Expectations Regarding
Terminated
- Ovarian Cancer
- Surveys
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 1, 2020
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Philadelphia (DC-Ova, DC Ova with Cyclophosphamide)
Completed
- Ovarian Cancer
- +2 more
- DC-Ova
- DC Ova with Cyclophosphamide
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 21, 2019
Ovarian Cancer Trial in Japan, United States (carboplatin, paclitaxel)
Completed
- Ovarian Cancer
-
Birmingham, Alabama
- +150 more
May 23, 2019
Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (enzastaurin HCl)
Completed
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer
- enzastaurin hydrochloride
-
Los Angeles, California
- +15 more
Mar 8, 2019